A citation-based method for searching scientific literature

Shusma C Doebar, Esther C van den Broek, Linetta B Koppert, Agnes Jager, Margreet H A Baaijens, Inge-Marie A M Obdeijn, Carolien H M van Deurzen. Breast Cancer Res Treat 2016
Times Cited: 30







List of co-cited articles
229 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
173
26

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.
G Pruneri, M Lazzeroni, V Bagnardi, G B Tiburzio, N Rotmensz, A DeCensi, A Guerrieri-Gonzaga, A Vingiani, G Curigliano, S Zurrida,[...]. Ann Oncol 2017
52
26

The immune microenvironment of breast ductal carcinoma in situ.
Elizabeth Thompson, Janis M Taube, Hillary Elwood, Rajni Sharma, Alan Meeker, Hind Nassar Warzecha, Pedram Argani, Ashley Cimino-Mathews, Leisha A Emens. Mod Pathol 2016
90
23


Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score.
Adriana Knopfelmacher, Jana Fox, Yungtai Lo, Nella Shapiro, Susan Fineberg. Mod Pathol 2015
33
20

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
318
20

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.
S E Clark, J Warwick, R Carpenter, R L Bowen, S W Duffy, J L Jones. Br J Cancer 2011
84
20

Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
Michael J Campbell, Frederick Baehner, Tess O'Meara, Ekene Ojukwu, Booyeon Han, Rita Mukhtar, Vickram Tandon, Max Endicott, Zelos Zhu, Jasmine Wong,[...]. Breast Cancer Res Treat 2017
63
20


CD8(+) tumor-infiltrating lymphocytes contribute to spontaneous "healing" in HER2-positive ductal carcinoma in situ.
Michi Morita, Rin Yamaguchi, Maki Tanaka, Gary M Tse, Miki Yamaguchi, Naoki Kanomata, Yoshiki Naito, Jun Akiba, Satoshi Hattori, Shigeki Minami,[...]. Cancer Med 2016
20
30

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.
Kylie L Gorringe, Stephen B Fox. Front Oncol 2017
57
20

Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.
Mieke Van Bockstal, Kathleen Lambein, Olivier Gevaert, Olivier De Wever, Marleen Praet, Veronique Cocquyt, Rudy Van den Broecke, Geert Braems, Hannelore Denys, Louis Libbrecht. Histopathology 2013
31
16

Progression from ductal carcinoma in situ to invasive breast cancer: revisited.
Catherine F Cowell, Britta Weigelt, Rita A Sakr, Charlotte K Y Ng, James Hicks, Tari A King, Jorge S Reis-Filho. Mol Oncol 2013
132
16


Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery,[...]. Clin Cancer Res 2008
111
16

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma.
Clint E Johnson, Kylie L Gorringe, Ella R Thompson, Ken Opeskin, Samantha E Boyle, Yuker Wang, Prue Hill, G Bruce Mann, Ian G Campbell. Breast Cancer Res Treat 2012
48
16

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
16

Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.
Mieke Van Bockstal, Kathleen Lambein, Hannelore Denys, Geert Braems, Ann Nuyts, Rudy Van den Broecke, Veronique Cocquyt, Olivier De Wever, Louis Libbrecht. Virchows Arch 2014
26
19

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
188
16

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
325
16

Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.
Islam Miligy, Priya Mohan, Ahmed Gaber, Mohammed A Aleskandarany, Christopher C Nolan, Maria Diez-Rodriguez, Abhik Mukherjee, Caroline Chapman, Ian O Ellis, Andrew R Green,[...]. Histopathology 2017
34
16

Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.
Thomas Fleischer, Arnoldo Frigessi, Kevin C Johnson, Hege Edvardsen, Nizar Touleimat, Jovana Klajic, Margit Lh Riis, Vilde D Haakensen, Fredrik Wärnberg, Bjørn Naume,[...]. Genome Biol 2014
121
16

Ductal carcinoma in situ of the breast.
Nicola L P Barnes, Jane L Ooi, John R Yarnold, Nigel J Bundred. BMJ 2012
22
22


Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
16


Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Emma J Groen, Lotte E Elshof, Lindy L Visser, Emiel J Th Rutgers, Hillegonda A O Winter-Warnars, Esther H Lips, Jelle Wesseling. Breast 2017
77
16

Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast.
Michael S Toss, I Miligy, Abdubaqi Al-Kawaz, Mansour Alsleem, Hazem Khout, Padmashree C Rida, Ritu Aneja, Andrew R Green, Ian O Ellis, Emad A Rakha. Mod Pathol 2018
40
16

Intraductal carcinoma of the breast: follow-up after biopsy only.
D L Page, W D Dupont, L W Rogers, M Landenberger. Cancer 1982
477
13


Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.
Shinn Young Kim, Seung-Hyun Jung, Min Sung Kim, In-Pyo Baek, Sung Hak Lee, Tae-Min Kim, Yeun-Jun Chung, Sug Hyung Lee. Oncotarget 2015
47
13

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
372
13

Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.
H Wong, S Lau, R Leung, J Chiu, P Cheung, T T Wong, R Liang, R J Epstein, T Yau. Med Oncol 2012
13
30

Ductal carcinoma in situ of the breast.
Harold J Burstein, Kornelia Polyak, Julia S Wong, Susan C Lester, Carolyn M Kaelin. N Engl J Med 2004
387
13

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
88
13

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
Kalliopi P Siziopikou, Stewart J Anderson, Melody A Cobleigh, Thomas B Julian, Douglas W Arthur, Ping Zheng, Eleftherios P Mamounas, Eduardo R Pajon, Robert J Behrens, Janice F Eakle,[...]. Breast Cancer Res Treat 2013
40
13

Gene amplification in ductal carcinoma in situ of the breast.
L Burkhardt, T J Grob, I Hermann, E Burandt, M Choschzick, F Jänicke, V Müller, C Bokemeyer, R Simon, G Sauter,[...]. Breast Cancer Res Treat 2010
53
13

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
231
13

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
225
13

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Aslaug Aamodt Muggerud, Michael Hallett, Hilde Johnsen, Kristine Kleivi, Wenjing Zhou, Simin Tahmasebpoor, Rose-Marie Amini, Johan Botling, Anne-Lise Børresen-Dale, Therese Sørlie,[...]. Mol Oncol 2010
80
13

A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.
Martin C Abba, Ting Gong, Yue Lu, Jaeho Lee, Yi Zhong, Ezequiel Lacunza, Matias Butti, Yoko Takata, Sally Gaddis, Jianjun Shen,[...]. Cancer Res 2015
79
13

Angiogenesis and inflammation in ductal carcinoma in situ of the breast.
A H Lee, L C Happerfield, L G Bobrow, R R Millis. J Pathol 1997
56
13

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Frederick L Baehner, Refik Saskin, Steven M Butler, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A Jani,[...]. Breast Cancer Res Treat 2015
138
13


Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features.
Shona Hendry, Jia-Min B Pang, David J Byrne, Sunil R Lakhani, Margaret C Cummings, Ian G Campbell, G Bruce Mann, Kylie L Gorringe, Stephen B Fox. Clin Cancer Res 2017
41
13

Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.
Robert Lesurf, Miriam Ragle Aure, Hanne Håberg Mørk, Valeria Vitelli, Steinar Lundgren, Anne-Lise Børresen-Dale, Vessela Kristensen, Fredrik Wärnberg, Michael Hallett, Therese Sørlie. Cell Rep 2016
48
13

Ductal carcinoma in situ: risk factors and impact of screening.
Beth A Virnig, Shi-Yi Wang, Tatyana Shamilyan, Robert L Kane, Todd M Tuttle. J Natl Cancer Inst Monogr 2010
44
13

The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ.
Michaela Semeraro, Julien Adam, Gautier Stoll, Emilie Louvet, Kariman Chaba, Vichnou Poirier-Colame, Allan Sauvat, Laura Senovilla, Erika Vacchelli, Norma Bloy,[...]. Oncoimmunology 2016
44
13

Characterization of high-grade ductal carcinoma in situ with and without regressive changes: diagnostic and biologic implications.
Mamatha Chivukula, Akosua Domfeh, Gloria Carter, George Tseng, David J Dabbs. Appl Immunohistochem Mol Morphol 2009
18
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.